Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists
US7226910B2 · kind B2 · utility
98Cited by
15References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2005 |
| Grant date | Jun 5, 2007 |
| Priority date | — |
| Expiry date | Oct 28, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating female sexual dysfunction are provided. A pharmaceutical composition containing a vasoactive agent selected from vasoactive intestinal potypeptide (VIP) and VIP agonists is administered to the vagina and/or vulvar region of the individual undergoing treatment. The formulations are also useful for improving vaginal muscle tone and tissue health, enhancing vaginal lubrication, and minimizing excess collagen deposition. Pharmaceutical formulations and kits are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.